Your browser doesn't support javascript.
loading
The East-West late lumen loss study: Comparison of angiographic late lumen loss between Eastern and Western drug-eluting stent study cohorts.
Harrison, Robert W; Radhakrishnan, Vaishnavi; Allen, John C; Lam, Peter S; Allocco, Dominic J; Brar, Sandeep; Fahy, Martin; Zhang, Zhen; Fisher, Rebecca; Ikeno, Fumiaki; Généreux, Philippe; Kimura, Takeshi; Liu, Minglei; Lye, Weng Kit; Nagai, Hirofumi; Suzuki, Yuka; White, Roseann; Krucoff, Mitchell W.
Afiliação
  • Harrison RW; Duke University Medical Center/Duke Clinical Research Institute, Durham, NC. Electronic address: robert.w.harrison@duke.edu.
  • Radhakrishnan V; Duke University Medical Center/Duke Clinical Research Institute, Durham, NC.
  • Allen JC; Duke-NUS Medical School Singapore, Singapore.
  • Lam PS; Boston Scientific Corporation, Marlborough, MA.
  • Allocco DJ; Boston Scientific Corporation, Marlborough, MA.
  • Brar S; Medtronic, Inc., Santa Rosa, CA.
  • Fahy M; Medtronic, Inc., Santa Rosa, CA.
  • Zhang Z; Abbott Vascular, Santa Clara, CA.
  • Fisher R; Duke University Medical Center/Duke Clinical Research Institute, Durham, NC.
  • Ikeno F; Stanford University, Stanford, CA.
  • Généreux P; Cardiovascular Research Foundation, New York, NY.
  • Kimura T; Kyoto University, Kyoto, Japan.
  • Liu M; Medtronic, Inc., Santa Rosa, CA.
  • Lye WK; Duke-NUS Medical School Singapore, Singapore.
  • Nagai H; Terumo Corporation, Tokyo, Japan.
  • Suzuki Y; Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • White R; Duke University Medical Center/Duke Clinical Research Institute, Durham, NC.
  • Krucoff MW; Duke University Medical Center/Duke Clinical Research Institute, Durham, NC.
Am Heart J ; 206: 61-71, 2018 12.
Article em En | MEDLINE | ID: mdl-30342296
BACKGROUND: Regulatory decisions approving new coronary drug-eluting stent (DES) require mechanistic observations of angiographic late lumen loss (LLL). Patient safety and device approval times could be enhanced if angiographic follow-up data were found to be generalizable across jurisdictions and geographies. The objectives were to assess the comparability of in-segment LLL in Eastern and Western DES populations using the world's largest compilation of follow-up quantitative coronary angiography data. METHODS: Data from 4 manufacturers involving 29 DES clinical trials in Eastern and Western hemispheres were compiled. "East" and "West" cohorts were defined by trial location. Independent core laboratories quantified in-segment LLL for all studies. East and West were compared before and after adjustment for clinical and anatomic covariates known to correlate with LLL via conditioning on propensity score quintiles. An international panel of experts and regulators prospectively established a clinically meaningful difference between East and West mean in-segment LLL of ±0.40 mm. RESULTS: The data set comprised 2,047 East and 4,456 West patients. Unadjusted mean ± SD for West and East in-segment LLL (mm) was 0.25 ± 0.46 and 0.12 ± 0.42, respectively (difference 0.13 mm; 95% CI 0.11-0.16). Propensity score-adjusted in-segment LLL East and West least squares means were 0.11 and 0.26 mm, respectively (difference 0.15 mm; 95% CI 0.13-0.18). CONCLUSIONS: In the world's largest compilation of DES protocol 8- to 13-month angiographic follow-up data, clinically meaningful comparability of in-segment LLL by independent core laboratory quantitative coronary angiography in East and West cohorts was demonstrated in both unadjusted and adjusted comparisons. These findings suggest that DES LLL, once characterized, could be generalized across regulatory jurisdictions over the course of global registration efforts.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Vasos Coronários / Grupos Raciais / Stents Farmacológicos / Intervenção Coronária Percutânea Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am Heart J Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Vasos Coronários / Grupos Raciais / Stents Farmacológicos / Intervenção Coronária Percutânea Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am Heart J Ano de publicação: 2018 Tipo de documento: Article